RegenXBio (RGNX)
NASDAQ:RGNX

RegenXBio (RGNX) Stock Forecast & Price Target

420 Followers
See the Price Targets and Ratings of:

RGNX Analyst Ratings

Moderate Buy
7Ratings
4 Buy
3 Hold
0 Sell
Based on 7 analysts giving stock ratings to
RegenXBio
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RGNX Stock 12 Months Forecast

Average Price Target

$40.00
▲(76.76% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for RegenXBio in the last 3 months. The average price target is $40.00 with a high forecast of $61.00 and a low forecast of $14.00. The average price target represents a 76.76% change from the last price of $22.63.
Highest Price Target$61.00Average Price Target$40.00Lowest Price Target$14.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
UBS
$47.00
Buy
107.69%
Upside
Reiterated
UBS Maintains Buy on Regenxbio, Lowers Price Target to $47
Bank of America Securities
$60.00
Buy
165.13%
Upside
Reiterated
BofA Securities Thinks Regenxbio Inc. (RGNX) Can More Than Double After Meeting with ManagementThe analyst stated "Following our conversations, we continue to view the current share price as undervaluing the potential upside from Regenxbios pipeline, with only cash ($534M ended 3Q21, not including $370M upfront from AbbVie), partial value for RGX-314, and license agreements baked into the stock currently.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

RGNX Financial Forecast

RGNX Earnings Forecast
Next quarter’s earnings estimate for RGNX is -$0.90 with a range of -$1.67 to $1.35. The previous quarter’s EPS was -$1.75. RGNX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.49% of the time in the same period. In the last calendar year RGNX has Underperformed its overall industry.
Next quarter’s earnings estimate for RGNX is -$0.90 with a range of -$1.67 to $1.35. The previous quarter’s EPS was -$1.75. RGNX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.49% of the time in the same period. In the last calendar year RGNX has Underperformed its overall industry.
RGNX Sales Forecast
Next quarter’s sales forecast for RGNX is $55.81M with a range of $26.51M to $135.80M. The previous quarter’s sales results were $26.51M. RGNX beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 42.83% of the time in the same period. In the last calendar year RGNX has Underperformed its overall industry.
Next quarter’s sales forecast for RGNX is $55.81M with a range of $26.51M to $135.80M. The previous quarter’s sales results were $26.51M. RGNX beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 42.83% of the time in the same period. In the last calendar year RGNX has Underperformed its overall industry.
RGNX Analyst Recommendation Trends
In the current month, RGNX has received 4 Buy ratings 3 Hold ratings, and 0 Sell ratings. The RGNX average analyst price target in the past 3 months is $40.00
In the current month, RGNX has received 4 Buy ratings 3 Hold ratings, and 0 Sell ratings. The RGNX average analyst price target in the past 3 months is $40.00

RGNX Stock Forecast FAQ

What is RGNX’s average 12-month price target, according to analysts?
Based on analyst ratings, RegenXBio’s 12-month average price target is $40.00.
    What is RGNX’s upside potential, based on the analysts’ average price target?
    RegenXBio has 76.76% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is RGNX a Buy, Sell or Hold?
          RegenXBio has a conensus rating of Moderate Buy which is based on 4 buy ratings, 3 hold ratings and 0 sell ratings.
            What is RegenXBio’s price target?
            The average price target for RegenXBio is $40.00. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $61.00 ,the lowest forecast is $14.00. The average price target represents 76.76% Increase from the current price of $22.63.
              What do analysts say about RegenXBio?
              RegenXBio’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis